News

We are happy to inform about new grants for the breakthrough research under the IDUB programme, which were given to the following researchers representing POB1:

• mgr inż. Mateusz D. Tomczyk (RCH): The use of sulfonylureas as HK2 inhibitors in anti-cancer therapies – 35.000 zł;
• dr hab. inż. Grzegorz Chladek, prof. PŚ (RMT); dr hab. inż. Izabela Barszczewska-Rybarek, prof. PŚ (RCH): Development and studies on antimicrobial hybrid composite nanomaterials enriched with particles of quaternary ammonium derivatives of polyethyleneimine – 34.000 zł;
• dr hab. inż. Katarzyna Krukiewicz, prof. PŚ (RCH): Electrospun medical fabrics and surgical threads with anti-cancer properties – 35.000 zł;
• dr hab. inż. Arkadiusz Gertych, prof. wizytujący PŚ (RIB); dr hab. inż. Karolina Nurzyńska, prof. PŚ (RAU); dr inż. lek. Bartłomiej Pyciński (RIB): Identification of the presence of gene mutations in a non-small cell lung cancer using computational pathology – 35.000 zł;
• dr inż. Agata Blacha-Grzechnik (RCH): Quantum dots in the photogeneration of singlet oxygen – 35.000 zł;
• mgr inż. Maciej Mrówka (Biotechnology Center): Water-soluble derivatives of flavonoids with anti-cancer activity – 35.000 zł.